Ar HIV inficētas mātes intrauterīnas augļa HIV inficēšanās prognozēšanas paņēmiens pirmajos sešos grūtniecības mēnešos

Jeļena Eglīte (Inventor), Diāna Kasjko (Inventor), Vladislavs Jasinskis (Inventor), Elvīra Hagina (Inventor), Inga Januškeviča (Inventor), Gunta Stūre (Inventor), Baiba Rozentāle (Inventor), Jeļena Storoženko (Inventor), Ludmila Vīksna (Inventor)

Research output: Intellectual propertyPatent

Abstract

Invention relates to medicine, particularly to infectious diseases and molecular genetic investigations. It may be used in prognosing risk of intrauterin
HIV infection in foetuses during the first six months of pregnancy. The method provides for detection of TNFα, IL2, IL4, IL12β, IL10, INFɣ mutations in mother blood leukocytes and measuring level of IL2, IL12 cytokines in peripherial blood serum of pregnant HIV infected mother.
Translated title of the contributionAr HIV inficētas mātes intrauterīnas augļa HIV inficēšanās prognozēšanas paņēmiens pirmajos sešos grūtniecības mēnešos
Original languageLatvian
Patent number15 133
IPCG01N33/53,GO1N33/543
Priority date9/03/16
Filing date9/03/16
Publication statusPublished - 20 Jan 2017

Keywords*

  • prognosing risk of intrauterin HIV infection

Field of Science*

  • 3.2 Clinical medicine

Fingerprint

Dive into the research topics of 'Ar HIV inficētas mātes intrauterīnas augļa HIV inficēšanās prognozēšanas paņēmiens pirmajos sešos grūtniecības mēnešos'. Together they form a unique fingerprint.

Cite this